CClinicalTrials.gg
CompletedNCT02817438RADCATUpdated Mar 20, 2019

Research on Anxiety and Depression: Computer-Assisted Therapy

An interventional study of Good Days Ahead in Mood Disorders and Anxiety Disorders, sponsored by Stanford University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-03-20.

Sponsored by Stanford University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
136
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study examines how online self-guided programs can improve mood and anxiety symptoms. These programs use exercises from Cognitive-Behavioral Therapy, which is an evidence-based treatment for depression and anxiety. The purpose of this study is to learn who will do best with the online format. Our aim is to learn for whom online self-guided interventions are most efficacious. This knowledge is important because it will help inform clinicians and patients about who might benefit from this type of intervention versus who would need the assistance of a therapist. More specifically, we hope to figure out who would benefit from solely an online intervention and who would benefit from an online intervention in addition to other treatment.

02

Conditions studied

  • Mood Disorders
  • Anxiety Disorders
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 136 is above the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Stanford University is the lead sponsor of 2,117 studies on the registry; 425 are open to participants now.

Of its 259 completed or terminated interventional studies of FDA-regulated products, 197 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Previous participation in the RAD study in our laboratory

RAD study inclusion criteria are:

  • 18+ years of age
  • Fluent and literate in English
  • Can provide informed consent
  • fMRI scanning eligibility, including no evidence of any form of metal embedded in the body (e.g., metal wires, nuts, bolts, screws, plates, sutures)

Exclusion criteria

Exclusion Criteria:

  • Anyone who has not already completed the RAD study will be excluded.

RAD study exclusion criteria are:

  • Presence of suicidal ideations representing imminent risk
  • General medical condition, disease, or neurological disorder that interferes with the assessments
  • Mild traumatic brain injury (history of physical brain injury or blow to the head resulting in loss of consciousness greater than five minutes) and which could interfere with doing the assessments
  • Severe impediment to vision, hearing and/or hand movement, likely to interfere with ability to complete the assessments
  • Unable and/or unlikely to follow the study protocols
  • Pregnant or breastfeeding
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
136 participants (actual)

Study arms

  • Experimental
    Online Intervention

    Participants randomized to the online intervention arm will be given access to the Good Days Ahead program for 12 weeks.

    Behavioral: Good Days Ahead

  • No intervention
    Waitlist

    Participants randomized to the waitlist arm will wait for 12 weeks without doing an online intervention.

Interventions

  • BehavioralGood Days Ahead

    Good Days Ahead is a web-based program based on the principles of Cognitive Behavioral Therapy (CBT). It can be used to supplement traditional psychotherapy, or as a stand-alone intervention. There are 9 lessons that address Thinking Skills, Behavioral Skills, Schemas, and Coping Tools. Lessons include videos from expert therapists and a Practice Section in which patients complete forms for self-monitoring symptoms and challenging negative thoughts.

06

What researchers measure

Primary outcomes

  1. Depression and Anxiety Composite Score

    Composite score combining 3 measures of depression and/or anxiety (PHQ-9, BAI, DASS)

    Time frame: 12 weeks

Secondary outcomes

  1. Quality of Life

    WHOQOL scale

    Time frame: 12 weeks

07

Study locations

1 site
  • Stanford University
    Stanford, California 94305, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 20, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02817438
Lead sponsor
Stanford University
Responsible party
Tali Manber Ball, PhD (Postdoctoral Scholar, Stanford University) — Principal investigator
First posted
Jun 29, 2016
Start date
Jun 2016
Primary completion
Mar 2018
Completion
Mar 2018
Last update
Mar 20, 2019

Study contacts

Tali Ball, PhD
principal investigator · Stanford University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion